AL-S Pharma

Quick facts

Phase 2 pipeline

• AP-101 · Psychiatry
  AP-101 is a small molecule that targets the serotonin receptor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• AL-S Pharma portfolio CI brief
• AL-S Pharma pipeline updates RSS

Related

• Sector hub: All tracked pharma companies